PBYI Message Board Post 9817722 | Puma Biotechnology Inc
home / stock / pbyi / pbyi message board
racebrakesshop
(investorshub)
Posted on: Sep/12/2019 14:49:43
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151090995
$PBYI two docs are in FDA ready.Solid tumors
News, Short Squeeze, Breakout and More Instantly...
-
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced the presentation of alisertib for the treatment of patients with advanced osimertinib-resistant epidermal growth factor receptor-mutated (EGFR-mutated) non-small cell lung cancer (NCT04085315) at the 2024 American Soc...
-
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced the presentation of biomarker findings from a Phase II randomized clinical trial of alisertib alone vs. alisertib + fulvestrant for the treatment of patients with endocrine and CDK4/6 inhibitor (CDK 4/6i) resistant, h...
-
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, is set to join the broad-market Russell 3000 ® Index at the conclusion of Russell Investments’ annual reconstitution of its comprehensive set of U.S. and global equity indexes on June 28 and effective after U.S....